Hence, it can be speculated that a reduced bioavailability of the substrate L-Arg for the NOS through NOS inhibition by ADMA and an increased activity of the competing arginase enzymes shown in CF [33,35] also may play a role in PCD due to similar airway inflammatory states. This evidence concerns the gene NOS1 and cystic fibrosis.